Ragweed Mix (Woodmont Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRagweed Mix (Woodmont Pharmaceuticals)
Drug Alias NameRagweed Mix
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWoodmont Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesWoodmont Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsConjunctivitis, AllergicRhinitis, Allergic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A